New York Times -- WASHINGTON — Expensive biotechnology drugs would face competition from cheaper copycats, setting off a bruising battle between big drug makers and consumer advocates, under a bipartisan proposal introduced Thursday in the Senate.
New York Times -- WASHINGTON — Expensive biotechnology drugs would face competition from cheaper copycats, setting off a bruising battle between big drug makers and consumer advocates, under a bipartisan proposal introduced Thursday in the Senate.
